Helicobacter pylori infection in patients with haemophilia in Poland: prevalence and risk of upper gastrointestinal bleeding.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 376, doi. 10.1111/j.1365-2516.2005.01086.x
- By:
- Publication type:
- Article
Works matching IS 13518216 AND DT 2005 AND VI 11 AND IP 4
Results: 25
1
2
Thromboelastography measurements of whole blood from factor VIII-deficient mice supplemented with rFVIII.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 346, doi. 10.1111/j.1365-2516.2005.01104.x
- By:
- Publication type:
- Article
3
Severe factor V deficiency and pregnancy – a role for solvent–detergent plasma?
- Published in:
- 2005
- By:
- Publication type:
- Letter
4
Thrombin generation and phenotypic correlation in haemophilia A.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 326, doi. 10.1111/j.1365-2516.2005.01107.x
- By:
- Publication type:
- Article
5
First giant gluteal neurofibroma reported in the literature in a person with haemophilia and its high risk of massive bleeding to death.
- Published in:
- 2005
- By:
- Publication type:
- Letter
6
Can activated recombinant factor VII be used to postpone the exposure of infants to factor VIII until after 2 years of age?
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 335, doi. 10.1111/j.1365-2516.2005.01088.x
- By:
- Publication type:
- Article
7
Factor VIII inhibitor associated with peginterferon.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 408, doi. 10.1111/j.1365-2516.2005.01089.x
- By:
- Publication type:
- Article
8
In vitro evaluation of B-domain deleted recombinant factor VIII (ReFacto<sup>®</sup>) stability during simulated continuous infusion administration.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 319, doi. 10.1111/j.1365-2516.2005.01094.x
- By:
- Publication type:
- Article
9
Haemophilia-related morbidity and quality-of-life.
- Published in:
- 2005
- By:
- Publication type:
- Letter
10
Treatment of intracranial and extracranial haemorrhages in a neonate with severe haemophilia B with recombinant factor IX infusion.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 411, doi. 10.1111/j.1365-2516.2005.01102.x
- By:
- Publication type:
- Article
11
Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 415, doi. 10.1111/j.1365-2516.2005.01103.x
- By:
- Publication type:
- Article
12
More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 295, doi. 10.1111/j.1365-2516.2005.01108.x
- By:
- Publication type:
- Article
13
Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 360, doi. 10.1111/j.1365-2516.2005.01109.x
- By:
- Publication type:
- Article
14
The effect of clotting factor concentrates on the immune system in HIV-negative haemophilics.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 366, doi. 10.1111/j.1365-2516.2005.01110.x
- By:
- Publication type:
- Article
15
The molecular analysis of haemophilia A: a guideline from the UK haemophilia centre doctors’ organization haemophilia genetics laboratory network.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 387, doi. 10.1111/j.1365-2516.2005.01111.x
- By:
- Publication type:
- Article
16
The molecular analysis of haemophilia B: a guideline from the UK haemophilia centre doctors’ organization haemophilia genetics laboratory network.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 398, doi. 10.1111/j.1365-2516.2005.01112.x
- By:
- Publication type:
- Article
17
HLA antigens as predictors of disease progression in HIV-infected haemophilia patients (a 22 years’ follow up).
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 371, doi. 10.1111/j.1365-2516.2005.01113.x
- By:
- Publication type:
- Article
18
Recommendations for postmarketing surveillance studies in haemophilia and other bleeding disorders.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 353, doi. 10.1111/j.1365-2516.2005.01114.x
- By:
- Publication type:
- Article
19
Immune tolerance in children with factors VIII and IX inhibitors: a single centre experience.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 340, doi. 10.1111/j.1365-2516.2005.01115.x
- By:
- Publication type:
- Article
20
Bone properties and muscle strength of young haemophilia patients.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 380, doi. 10.1111/j.1365-2516.2005.01116.x
- By:
- Publication type:
- Article
21
Assessing functional health status in adults with haemophilia: towards a preliminary core set of clinimetric instruments based on a literature search in Rheumatoid Arthritis and Osteoarthritis.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 308, doi. 10.1111/j.1365-2516.2005.01117.x
- By:
- Publication type:
- Article
22
Inherited coagulation disorders in the northwestern region of Iran.
- Published in:
- 2005
- By:
- Publication type:
- Letter
23
Haemophilia Inhibitor Genetics Study – evaluation of a model for studies of complex diseases using linkage and association methods.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 427, doi. 10.1111/j.1365-2516.2005.01119.x
- By:
- Publication type:
- Article
24
What dose of recombinant activated factor VII should be used in patients with factor XI deficiency?
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 430, doi. 10.1111/j.1365-2516.2005.01120.x
- By:
- Publication type:
- Article
25
Living donor liver transplantation for hepatitis C related hepatocellular carcinoma in a haemophilia A patient.
- Published in:
- Haemophilia, 2005, v. 11, n. 4, p. 405, doi. 10.1111/j.1365-2516.2005.00945.x
- By:
- Publication type:
- Article